Prebiotics (Inulin) is a type of food or fiber that is used to feed our gut bacteria. It is used to provide nutrients and increase the activity of our gut bacteria. Prebiotics is important to our health in maintaining the gut’s microbiota. It’s also shown to provide many health benefits such as reducing blood glucose and blood cholesterol.

According to Wang and his colleagues, they have done a systematic review and meta-analysis of 33 randomized controlled trials. Based on the study, they have found up that taking inulin in a median of 10g/day helps reduce blood sugar (HbA1c, fasting blood glucose, fasting insulin) and improves insulin resistance in 56days. The short summary of the research article was shown as below:

Pravin and his friends also did another study on the performance of Inulin supplements on glycemic status and lipid profile. The summary of the research was shown below:

In summary, prebiotic (Inulin) has shown many health benefits to humans. Why not take it now to control our blood sugar and cholesterol level. Now we can drink the “king” of whole grains, brown rice with prebiotic (Inulin) in just a cup with NutriBrownRice®️. GET IT NOW!!

References

Dehghan, P., Gargari, B. P., & Asgharijafarabadi, M. (2013). Effects of high-performance inulin supplementation on glycemic status and lipid profile in women with type 2 diabetes: a randomized, placebo-controlled clinical trial. Health promotion perspectives3(1), 55.

Gargari, B. P., Dehghan, P., Aliasgharzadeh, A., & Jafar-Abadi, M. A. (2013). Effects of high-performance inulin supplementation on glycemic control and antioxidant status in women with type 2 diabetes. Diabetes & metabolism journal37(2), 140.

Wang, L., Yang, H., Huang, H., Zhang, C., Zuo, H. X., Xu, P., … & Wu, S. S. (2019). Inulin-type fructans supplementation improves glycemic control for the prediabetes and types 2 diabetes populations: results from a GRADE-assessed systematic review and dose-response meta-analysis of 33 randomized controlled trials. Journal of translational medicine17(1), 1-19.